Hikal Share Price (HIKAL)
Check the latest share price of Hikal, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Hikal Stock Performance
Get live Hikal share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹371.4Day's Price Range₹377.8552 Week's Low
52 Week's High
₹294.352-Week Price Range₹464.75
| Returns % | |
| 1 Month Return | -10.84 % |
| 3 Month Return | -1.97 % |
| 1 Year Return | + 25.79 % |
| 3 Year Return | + 49.3 % |
| 5 Year Return | + 223.69 % |
| Market Stats | |
| Previous Close | ₹379.15 |
| Open | ₹374.85 |
| Volume | 1.73L |
| Upper Circuit | ₹454.95 |
| Lower Circuit | ₹303.35 |
Hikal Fundamentals & Key Indicators
Check Hikal market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹4,633.64 Cr
Return on Equity (ROE)
5.99
PE Ratio (TTM)
51.13
Return on capital employed (ROCE)
7.51
Industry PE ratio
57.39
Beta (LTM)
1.03
P/B Ratio
2.75
Dividend Yield
0.45
PEG Ratio
30.08
Quarterly Earnings Growth YOY
48.08
EPS (TTM)
5.64
Sector
Pharmaceuticals
Book Value
96.32
Technical Analysis
Bearish
View Technical Analysis
How to invest in Hikal?
Investing in Hikal is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Hikal or HIKAL on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Hikal or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Hikal with just a few clicks!
Hikal Stock's Interest Amongst Investors
Hikal Valuation
Track how Hikal P/E has moved over time to understand its valuation trends.
Hikal in the last 5 years
Lowest (8.33x)
March 24, 2020
Today (51.13x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (81.58x)
January 3, 2023
Today’s Price to Earnings Ratio: 51.13x
Hikal Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Hikal.
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Hikal. Average target price of ₹540
Source: S&P Global Market Intelligence
Hikal Share Price Target
Get share price movements and forecasts by analysts on Hikal.
Hikal price forecast by 1 analysts
Upside of43.69%
High
₹540
Target
₹540.00
Low
₹540
Hikal target price ₹540, a slight upside of 43.69% compared to current price of ₹375.8. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Hikal revenue growth forecast
Expected growth rate Q1, FY2027:34.32%
Forecast
Actual
Including amortisation and stock based compensations
Hikal EPS growth forecast
EPS estimate Q1, FY2027:197.87%
Forecast
Actual
Source: S&P Global Market Intelligence
Hikal Financial Results
Get the annual and quarterly financial summary of Hikal, including revenue, profit, loss and more.
Indices Featuring Hikal Stock
Check stock indices that include Hikal.
Hikal Earnings and Dividends
View detailed summary of the earnings and dividend history of Hikal.
Hikal Ltd Earnings Results
Hikal Ltd’s net profit jumped 48.08% since last year same period to ₹50.20Cr in the Q4 2024-2025. On a quarterly growth basis, Hikal Ltd has generated 191.86% jump in its net profits since last 3-months.
Read More about Earnings ResultsHikal Ltd Dividends February,2025
In the quarter ending December 2024, Hikal Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.48%.
Read More about Dividends
Hikal Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Hikal.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.85% | 0.00 | |
| Foreign Institutions | 5.69% | 0.00 | |
| Mutual Funds | 2.93% | 0.00 | |
| Retail Investors | 21.66% | 0.00 | |
| Others | 0.87% | 0.00 |
Hikal vs Peers
Compare market cap, revenue, PE, and other key metrics of Hikal with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 4,633.64 | 44.74% | 0.72 | 69 | 1,784 | |
| BUY | 38,428.87 | 101.79% | 0.52 | 300 | 1,051 | |
| BUY | 17,430.61 | 17.42% | 0.57 | 72 | 6,702 | |
| NA | 5,383.81 | 2.8% | 0.79 | -388 | 75 | |
| BUY | 14,436.59 | 43.15% | 0.68 | 244 | 1,515 |
Hikal News & Key Events
Latest news and events in one place to help you make informed investing decisions in Hikal.
Hikal Reports Strong Q4 Earnings Growth - 14 May, 2025
Hikal Limited's Q4 FY25 results show a 48% increase in net profit to ₹50.2 crore and a 7.4% rise in revenue to ₹552.4 crore. The company also reported a full-year net profit of ₹90.8 crore, up 30.5% from FY24, reflecting strong operational performance and margin expansion.Hikal Limited Updates RTA Contact Information - 18 Apr, 2025
Hikal Limited has updated the contact details for its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, enhancing communication and service efficiency for stakeholders.
Insights on Hikal Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 2.92% to 2.93% in Mar 2025 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 21.61% to 21.66% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 17.2 Cr → 50.2 Cr (in ₹), with an average increase of 65.7% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 451.3 Cr → 552.9 Cr (in ₹), with an average increase of 18.4% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 81.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.85% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 19.5%
NEGATIVE IMPACTPrice Dip
In the last 1 month, HIKAL stock has moved down by -10.8%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 6.06% to 5.69% in Mar 2025 quarter
About Hikal
Revenue: ₹550.00Cr as on March 2025 (Q4 FY25)
Net Profit: ₹50.20Cr as on March 2025 (Q4 FY25)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
| Organisation | Hikal Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Jai Hiremath |
| E-voting on shares | Click here to vote |
Mutual Funds that own Hikal
Check out the Mutual Funds with significant holdings in Hikal.
FAQs
What is Hikal share price today?
Hikal share price today stands at ₹375.8, Open: ₹374.85, Previous Close: ₹379.15, High: ₹377.85, Low: ₹371.4, 52 Week High: ₹464.75, 52 Week Low: ₹294.3.
What is today's traded volume of Hikal?
Today's traded volume of Hikal is 1.73L. Which means that 1.73L shares of Hikal were bought and sold on the stock market during today's trading session.
What is Hikal's market cap today?
Today's market capitalisation of Hikal is ₹4,633.64 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Hikal?
Hikal’s 52 week high is ₹464.75 and 52 week low is ₹294.3. The current share price of Hikal is ₹375.8, which is -19.14% down from its 52 week high and 27.69% up from its 52 week low.